Healthcare -
Biotechnology - NASDAQ - US
$ 8.2
3.67 %
$ 79.7 M
Market Cap
-0.23
P/E
Price Target
Average
21.95%
Revenue Forecast
Estimate
154.29%
EBIT
Estimate
--25.69%
Net Income
Estimate
26.06%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
bluebird bio, Inc.
Wall Street analysts predict an average 1-year price target for BLUE of $10 , with forecasts ranging from
a
low of
$5 to a high of $14 .
BLUE Lowest Price Target
Wall Street Target
5 USD
-39.02%
BLUE Average Price Target
Wall Street Target
10 USD
21.95%
BLUE Highest Price Target
Wall Street Target
14 USD
70.73%
REVENUE FORECAST
Revenue Forecast Chart BLUE
EBIT FORECAST
EBIT Forecast Chart BLUE
NET INCOME FORECAST
Net Income Chart BLUE